Literature DB >> 34158578

PARP14 regulates cyclin D1 expression to promote cell-cycle progression.

Michael J O'Connor1, Tanay Thakar1, Claudia M Nicolae1, George-Lucian Moldovan2.   

Abstract

Cyclin D1 is an essential regulator of the G1-S cell-cycle transition and is overexpressed in many cancers. Expression of cyclin D1 is under tight cellular regulation that is controlled by many signaling pathways. Here we report that PARP14, a member of the poly(ADP-ribose) polymerase (PARP) family, is a regulator of cyclin D1 expression. Depletion of PARP14 leads to decreased cyclin D1 protein levels. In cells with a functional retinoblastoma (RB) protein pathway, this results in G1 cell-cycle arrest and reduced proliferation. Mechanistically, we found that PARP14 controls cyclin D1 mRNA levels. Using luciferase assays, we show that PARP14 specifically regulates cyclin D1 3'UTR mRNA stability. Finally, we also provide evidence that G1 arrest in PARP14-depleted cells is dependent on an intact p53-p21 pathway. Our work uncovers a new role for PARP14 in promoting cell-cycle progression through both cyclin D1 and the p53 pathway.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34158578      PMCID: PMC8384455          DOI: 10.1038/s41388-021-01881-8

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  44 in total

1.  The identification of E2F1-specific target genes.

Authors:  Julie Wells; Carrie R Graveel; Stephanie M Bartley; Steven J Madore; Peggy J Farnham
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  New functional activities for the p21 family of CDK inhibitors.

Authors:  J LaBaer; M D Garrett; L F Stevenson; J M Slingerland; C Sandhu; H S Chou; A Fattaey; E Harlow
Journal:  Genes Dev       Date:  1997-04-01       Impact factor: 11.361

3.  Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.

Authors:  Seock-Ah Im; Yen-Shen Lu; Aditya Bardia; Nadia Harbeck; Marco Colleoni; Fabio Franke; Louis Chow; Joohyuk Sohn; Keun-Seok Lee; Saul Campos-Gomez; Rafael Villanueva-Vazquez; Kyung-Hae Jung; Arunava Chakravartty; Gareth Hughes; Ioannis Gounaris; Karen Rodriguez-Lorenc; Tetiana Taran; Sara Hurvitz; Debu Tripathy
Journal:  N Engl J Med       Date:  2019-06-04       Impact factor: 91.245

4.  RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response.

Authors:  Adam Ertel; Jeffry L Dean; Hallgeir Rui; Chengbao Liu; Agnes K Witkiewicz; Karen E Knudsen; Erik S Knudsen
Journal:  Cell Cycle       Date:  2010-10-27       Impact factor: 4.534

5.  Palbociclib and Letrozole in Advanced Breast Cancer.

Authors:  Richard S Finn; Miguel Martin; Hope S Rugo; Stephen Jones; Seock-Ah Im; Karen Gelmon; Nadia Harbeck; Oleg N Lipatov; Janice M Walshe; Stacy Moulder; Eric Gauthier; Dongrui R Lu; Sophia Randolph; Véronique Diéras; Dennis J Slamon
Journal:  N Engl J Med       Date:  2016-11-17       Impact factor: 91.245

6.  MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer.

Authors:  Matthew P Goetz; Masakazu Toi; Mario Campone; Joohyuk Sohn; Shani Paluch-Shimon; Jens Huober; In Hae Park; Olivier Trédan; Shin-Cheh Chen; Luis Manso; Orit C Freedman; Georgina Garnica Jaliffe; Tammy Forrester; Martin Frenzel; Susana Barriga; Ian C Smith; Nawel Bourayou; Angelo Di Leo
Journal:  J Clin Oncol       Date:  2017-10-02       Impact factor: 44.544

Review 7.  Transcriptional regulation of the cyclin D1 gene at a glance.

Authors:  Eric A Klein; Richard K Assoian
Journal:  J Cell Sci       Date:  2008-12-01       Impact factor: 5.285

8.  Inhibition of cyclin-dependent kinases by p21.

Authors:  J W Harper; S J Elledge; K Keyomarsi; B Dynlacht; L H Tsai; P Zhang; S Dobrowolski; C Bai; L Connell-Crowley; E Swindell
Journal:  Mol Biol Cell       Date:  1995-04       Impact factor: 4.138

Review 9.  Newly identified aspects of tumor suppression by RB.

Authors:  Patrick Viatour; Julien Sage
Journal:  Dis Model Mech       Date:  2011-09       Impact factor: 5.758

Review 10.  RB1: a prototype tumor suppressor and an enigma.

Authors:  Nicholas J Dyson
Journal:  Genes Dev       Date:  2016-07-01       Impact factor: 11.361

View more
  5 in total

1.  c-myc-mediated upregulation of NAT10 facilitates tumor development via cell cycle regulation in non-small cell lung cancer.

Authors:  Zimu Wang; Yicong Huang; Wanjun Lu; Jiaxin Liu; Xinying Li; Suhua Zhu; Hongbing Liu; Yong Song
Journal:  Med Oncol       Date:  2022-07-14       Impact factor: 3.738

2.  PARP14: A key ADP-ribosylating protein in host-virus interactions?

Authors:  Srivatsan Parthasarathy; Anthony R Fehr
Journal:  PLoS Pathog       Date:  2022-06-09       Impact factor: 7.464

3.  Molecular Regulation of Yak Preadipocyte Differentiation and Proliferation by LncFAM200B and ceRNA Regulatory Network Analysis.

Authors:  Hongbiao Ran; Youzhualamu Yang; Mengning Luo; Xinrui Liu; Binglin Yue; Zhixin Chai; Jincheng Zhong; Hui Wang
Journal:  Cells       Date:  2022-08-01       Impact factor: 7.666

4.  Human Umbilical Cord Mesenchymal Stem Cell-Derived Conditioned Medium Promotes Human Endometrial Cell Proliferation through Wnt/β-Catenin Signaling.

Authors:  Xiaoning Wei; Feiran Liu; Sichen Zhang; Xinyu Xu; Jin Li; Qingyu Wang; Jianping Cai; Shaowei Wang
Journal:  Biomed Res Int       Date:  2022-08-30       Impact factor: 3.246

5.  The KU-PARP14 axis differentially regulates DNA resection at stalled replication forks by MRE11 and EXO1.

Authors:  Ashna Dhoonmoon; Claudia M Nicolae; George-Lucian Moldovan
Journal:  Nat Commun       Date:  2022-08-27       Impact factor: 17.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.